Latest filing published 13 Jun 2018 for Madrigal Pharmaceuticals, INC., €442k.
This profile gathers the share dealings of Marc R. Schneebaum across 2 companies, led by Madrigal Pharmaceuticals, Inc. and Genvec Inc. In total, 10 filings cover trades dated from 16 June 2016 to 11 June 2018.
On the market, this insider has only sold: 1 sale, €2.5M in total. The rest of the record consists of 5 share grants and 3 option exercises. In 2018 alone, the filings show no purchases and 1 sale.
The latest filing, published on 13 June 2018, reports an option exercise of €442k in Madrigal Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations